Matches in SemOpenAlex for { <https://semopenalex.org/work/W1984700778> ?p ?o ?g. }
- W1984700778 endingPage "3261" @default.
- W1984700778 startingPage "3247" @default.
- W1984700778 abstract "Derivatives of a novel scaffold, C-phenyl 1-thio-d-glucitol, were prepared and evaluated for sodium-dependent glucose cotransporter (SGLT) 2 and SGLT1 inhibition activities. Optimization of substituents on the aromatic rings afforded five compounds with potent and selective SGLT2 inhibition activities. The compounds were evaluated for in vitro human metabolic stability, human serum protein binding (SPB), and Caco-2 permeability. Of them, (1S)-1,5-anhydro-1-[5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl]-1-thio-d-glucitol (3p) exhibited potent SGLT2 inhibition activity (IC50 = 2.26 nM), with 1650-fold selectivity over SGLT1. Compound 3p showed good metabolic stability toward cryo-preserved human hepatic clearance, lower SPB, and moderate Caco-2 permeability. Since 3p should have acceptable human pharmacokinetics (PK) properties, it could be a clinical candidate for treating type 2 diabetes. We observed that compound 3p exhibits a blood glucose lowering effect, excellent urinary glucose excretion properties, and promising PK profiles in animals. Phase II clinical trials of 3p (TS-071) are currently ongoing." @default.
- W1984700778 created "2016-06-24" @default.
- W1984700778 creator A5003975586 @default.
- W1984700778 creator A5014085004 @default.
- W1984700778 creator A5015614314 @default.
- W1984700778 creator A5025204867 @default.
- W1984700778 creator A5029228118 @default.
- W1984700778 creator A5033625308 @default.
- W1984700778 creator A5035921264 @default.
- W1984700778 creator A5038079325 @default.
- W1984700778 creator A5038567826 @default.
- W1984700778 creator A5048669756 @default.
- W1984700778 creator A5053625137 @default.
- W1984700778 creator A5057118366 @default.
- W1984700778 creator A5059509332 @default.
- W1984700778 creator A5065745083 @default.
- W1984700778 creator A5068587130 @default.
- W1984700778 creator A5072741660 @default.
- W1984700778 creator A5082163138 @default.
- W1984700778 creator A5011625195 @default.
- W1984700778 date "2010-03-19" @default.
- W1984700778 modified "2023-10-12" @default.
- W1984700778 title "(1<i>S</i>)-1,5-Anhydro-1-[5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl]-1-thio-<scp>d</scp>-glucitol (TS-071) is a Potent, Selective Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for Type 2 Diabetes Treatment" @default.
- W1984700778 cites W1963542379 @default.
- W1984700778 cites W1967998641 @default.
- W1984700778 cites W1968062717 @default.
- W1984700778 cites W1988155918 @default.
- W1984700778 cites W2010781138 @default.
- W1984700778 cites W2011044340 @default.
- W1984700778 cites W2026609170 @default.
- W1984700778 cites W2031484324 @default.
- W1984700778 cites W2031940954 @default.
- W1984700778 cites W2034253945 @default.
- W1984700778 cites W2036227043 @default.
- W1984700778 cites W2038856804 @default.
- W1984700778 cites W2041780259 @default.
- W1984700778 cites W2046827775 @default.
- W1984700778 cites W2051892077 @default.
- W1984700778 cites W2053119517 @default.
- W1984700778 cites W2053679882 @default.
- W1984700778 cites W2054866483 @default.
- W1984700778 cites W2068662257 @default.
- W1984700778 cites W2075080580 @default.
- W1984700778 cites W2078992128 @default.
- W1984700778 cites W2082767535 @default.
- W1984700778 cites W2083473802 @default.
- W1984700778 cites W2091203103 @default.
- W1984700778 cites W2091390239 @default.
- W1984700778 cites W2106558322 @default.
- W1984700778 cites W2130110051 @default.
- W1984700778 cites W2135152819 @default.
- W1984700778 cites W2144173715 @default.
- W1984700778 cites W2152211669 @default.
- W1984700778 cites W2159788755 @default.
- W1984700778 cites W2163402237 @default.
- W1984700778 cites W2177236071 @default.
- W1984700778 cites W2950897586 @default.
- W1984700778 cites W2953032419 @default.
- W1984700778 cites W2953351625 @default.
- W1984700778 cites W4233417345 @default.
- W1984700778 cites W4239442385 @default.
- W1984700778 cites W4300466067 @default.
- W1984700778 cites W4376848383 @default.
- W1984700778 doi "https://doi.org/10.1021/jm901893x" @default.
- W1984700778 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20302302" @default.
- W1984700778 hasPublicationYear "2010" @default.
- W1984700778 type Work @default.
- W1984700778 sameAs 1984700778 @default.
- W1984700778 citedByCount "129" @default.
- W1984700778 countsByYear W19847007782012 @default.
- W1984700778 countsByYear W19847007782013 @default.
- W1984700778 countsByYear W19847007782014 @default.
- W1984700778 countsByYear W19847007782015 @default.
- W1984700778 countsByYear W19847007782016 @default.
- W1984700778 countsByYear W19847007782017 @default.
- W1984700778 countsByYear W19847007782018 @default.
- W1984700778 countsByYear W19847007782019 @default.
- W1984700778 countsByYear W19847007782020 @default.
- W1984700778 countsByYear W19847007782021 @default.
- W1984700778 countsByYear W19847007782022 @default.
- W1984700778 countsByYear W19847007782023 @default.
- W1984700778 crossrefType "journal-article" @default.
- W1984700778 hasAuthorship W1984700778A5003975586 @default.
- W1984700778 hasAuthorship W1984700778A5011625195 @default.
- W1984700778 hasAuthorship W1984700778A5014085004 @default.
- W1984700778 hasAuthorship W1984700778A5015614314 @default.
- W1984700778 hasAuthorship W1984700778A5025204867 @default.
- W1984700778 hasAuthorship W1984700778A5029228118 @default.
- W1984700778 hasAuthorship W1984700778A5033625308 @default.
- W1984700778 hasAuthorship W1984700778A5035921264 @default.
- W1984700778 hasAuthorship W1984700778A5038079325 @default.
- W1984700778 hasAuthorship W1984700778A5038567826 @default.
- W1984700778 hasAuthorship W1984700778A5048669756 @default.
- W1984700778 hasAuthorship W1984700778A5053625137 @default.
- W1984700778 hasAuthorship W1984700778A5057118366 @default.
- W1984700778 hasAuthorship W1984700778A5059509332 @default.
- W1984700778 hasAuthorship W1984700778A5065745083 @default.
- W1984700778 hasAuthorship W1984700778A5068587130 @default.